Prospecting the Intricate Role of Novel and Potent Biomarkers in Schizophrenia

Author(s): Rajwinder Kaur, Ankita Sood, Damanpreet Kaur Lang, Ravi Goyal, Balraj Saini*

Journal Name: Current Topics in Medicinal Chemistry

Volume 21 , Issue 16 , 2021

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Schizophrenia is a serious psychiatric disorder leading to cognitive impairment and has higher rates of morbidity and mortality. There is a need to understand the mechanisms underlying the onset and progression of the disease as the clinical presentation may vary in patients and inadequate knowledge of neurochemical alterations can lead to decreased efficacy in treatment which makes it necessary to identify new potent biomarkers. Identification of biomarkers in schizophrenia offers significant benefits to the well-being of patients, including better prognosis, diagnosis, detection, screening, enhancement in treatment efficacy, prevention of relapse, and better clinical results. Incorporation of advanced technological techniques is necessary to provide an approach for the diagnosis and treatment of psychiatric disorders and to permit specific therapeutic interventions. This review highlights the particulars about the current use and application of various biomarkers such as proteomics, miRNAs, language techniques, antibodies, blood biomarkers, gut microbiota, such as analysis, neuroimaging techniques, and inflammatory biomarkers in effective prognosis, detection, and treatment of schizophrenia and which would contribute as an additional tool for a psychiatrist in cases where an appropriate diagnosis is lacking clarity.

Keywords: Schizophrenia, Biomarkers, Gut microbiota, Theranostics, Neuroimaging, Psychiatric disorders.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 21 May, 2021
Page: [1441 - 1456]
Pages: 16
DOI: 10.2174/1568026621666210521162832
Price: $65

Article Metrics

PDF: 55